drugset / Trial / NCT00655122
Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary objective was to study the clinical benefit with dalteparin sodium in thromboprophylaxis in primary care medical subjects. The secondary objective was a pharmacoeconomic evaluation of hromboprophylaxis with dalteparin sodium in primary care medical subjects.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalteparin sodium | Other / unclassified | 5000 iu | Subcutaneous |